Side effect profile by dose Gastrointestinal side effects were the most common adverse events and were clearly dose-related
The early efficacy profile of tirzepatide after treatment initiation is of interest
"...Bottom line, I think it's fantastic science, it's fantastic biology, this is great for public health in the short term, and I think the concerns are overblown." Longer term, say about 15 years to 20 years out, Ford said he sees a lot of unanswered questions still regarding GLP-1 drugs and their impact in medtech.
Lesions are mostly small (5-10 mm), but many are considerably larger with up to 2 cm
This was not a minor observation
How to take it: Inject on the same day each week, at any time of day, in your abdomen, thigh, or upper arm